Summary
Dr. Susie G interviews Dr. Rachel Rubin, a urologist fellowship-trained in male and female sexual medicine, about low-intensity shockwave therapy for erectile dysfunction and other sexual health conditions. Dr. Rubin discusses commonly used urological medications, their impacts on male sexual health, and the emerging evidence for shockwave therapy in treating ED, pain, and premature ejaculation. Dr. Rubin shares details about her pioneering clinical trial in the US studying shockwave therapy for ED, making her practice the first to conduct such a trial. The conversation covers what the current research shows, realistic expectations, and how shockwave fits into the broader landscape of ED treatments alongside medications and other interventions.
Key Points
- Dr. Rubin is conducting the first US clinical trial on low-intensity shockwave therapy for ED
- Shockwave therapy is being investigated for ED, penile pain, and premature ejaculation
- Common urological medications can have significant impacts on male sexual health
- ESWT represents a potentially restorative approach versus symptom-masking medications
- European guidelines already approve shockwave for vasculogenic ED
- The treatment is non-invasive with minimal side effects reported in studies
- Research is still in early stages in the US compared to Europe where shockwave is more widely adopted
Key Moments
First US clinical trial on shockwave therapy for ED
Dr. Rachel Rubin is running the first US clinical trial on low-intensity shockwave therapy for erectile dysfunction, pain, and premature ejaculation, bringing rigorous evidence-based research to a treatment that has been more widely used in Europe.
"We're also going to be chatting a lot about a new modality called low-intensity shockwave therapy for erectile dysfunction, pain, premature ejaculation. We're going to be talking about what does the research say so far."
European guidelines already approve shockwave for vasculogenic ED
While the US is still in early clinical trial stages, European medical guidelines already approve low-intensity shockwave therapy for vasculogenic erectile dysfunction based on existing evidence.
"Dr. Rubin also shares with us her current clinical trial in the U.S. She's the only one. They're the first ones to be doing this at her office."
Shockwave as a non-invasive alternative to medications
The episode explores how shockwave therapy offers a non-invasive approach to sexual health that could reduce reliance on medications, with Dr. Rubin providing expert insight on commonly used urological drugs and their sexual health side effects.
"Today, we're going to be talking about some of the commonly used medications by urologists and their impacts on male sexual health."
